Navigation Links
Leptin has powerful effect on reward center in the brain

Leptin, a hormone critical for normal food intake and metabolism, exerts a strong effect on appetite by acting in the mid-brain region as well as in the hypothalamus, according to a Yale School of Medicine study in Neuron.

"Finding that metabolic hormones directly regulate the ventral tegmental area (VTA) of the mid-brain has profound implications for how researchers view the integration of metabolic signals in the brain," said the senior author, Ralph DiLeone, assistant professor of psychiatry.

In this study the researchers demonstrated that leptin signaling, via its receptor, occurs in the dopamine neurons in the VTA and that it results in decreased activity of these neurons.

"Metabolic control over dopamine neuron function in the VTA is likely to have consequences for a broad range of behaviors and associated pathologies," DiLeone said. "These include obesity, drug addiction, and other impulsive behavior."

Leptin's effect in the hypothalamus has been well studied, but it was not known how the hormone affected activity in the VTA, which contains dopamine neurons that are important in modulating motivated behavior, addiction and reward.

Reducing the function of the leptin receptor in the VTA region resulted in animals that ate too much and were hypersensitive to highly palatable foods. "Interestingly, despite the increase in food intake, these animals did not gain weight, possibly as a result of increased activity that was also seen in the animals," DiLeone said.

Food intake is influenced by signals that travel from the body to the brain. Leptin is one of the molecules that signals the brain to modulate food intake. It is produced in fat cells and informs the brain of the metabolic state. If animals are missing leptin, or the leptin receptor, they eat too much and become severely obese.


Source:Yale University

Page: 1

Related biology news :

1. Leptin-signaling Protein Maintains Normal Body Weight And Energy Balance In Mice
2. Leptin found to control appetite and limb development in frogs
3. New drug shows promise as powerful anticancer agent
4. Mosaic mouse technique offers a powerful new tool to study diseases and genetics
5. License to kill enables powerful immune attack cells in mice
6. Nanoparticles, nanoshells, nanotubes: How tiny specks may provide powerful tools against cancer
7. A more powerful and efficient engine for rice: the C3-C4 challenge
8. Anticipation plays a powerful role in human memory, brain study finds
9. Gladstone investigators identify a new protective action for the powerful anti-HIV factor, APOBEC3G
10. Minuscule molecules pack a powerful punch
11. Scientists ID molecular switch in liver that triggers harmful effects of saturated and trans fats
Post Your Comments:

(Date:11/10/2015)... 10, 2015  In this report, the ... of product, type, application, disease indication, and ... report are consumables, services, software. The type ... biomarkers, efficacy biomarkers, and validation biomarkers. The ... diagnostics development, drug discovery and development, personalized ...
(Date:11/2/2015)... Calif. , Nov. 2, 2015  SRI International ... million to provide preclinical development services to the National ... contract, SRI will provide scientific expertise, modern testing and ... variety of preclinical pharmacology and toxicology studies to evaluate ... --> The PREVENT Cancer Drug Development Program ...
(Date:10/29/2015)... , Oct. 29, 2015  Connected health pioneer, ... driving the explosion of technology-enabled health and wellness, and ... new book, The Internet of Healthy Things ... sensors or smartphones even existed, Dr. Kvedar, vice president, ... of health care delivery, moving care from the hospital ...
Breaking Biology News(10 mins):
(Date:11/27/2015)... November 27, 2015 ... popularity of companion diagnostics is one of ... market with pharmaceutical companies and diagnostic manufacturers ... tests. . --> ... report on global cancer biomarkers market spread ...
(Date:11/25/2015)... , Nov. 25, 2015  PharmAthene, Inc. (NYSE MKT: ... adopted a stockholder rights plan (Rights Plan) in an ... loss carryforwards (NOLs) under Section 382 of the Internal ... --> PharmAthene,s use of its NOLs could be ... as defined in Section 382 of the Code. In ...
(Date:11/25/2015)... , Nov. 25, 2015  Neurocrine Biosciences, Inc. ... Gorman , President and CEO of Neurocrine Biosciences, will ... Conference in New York . ... visit the website approximately 5 minutes prior to the ... replay of the presentation will be available on the ...
(Date:11/25/2015)... PORTLAND, Oregon , November 25, 2015 /PRNewswire/ ... Deep Market Research Report is a professional and ... Genomics industry.      (Logo: ... basic overview of the industry including definitions, classifications, ... analysis is provided for the international markets including ...
Breaking Biology Technology: